Meningitis B vaccine, Bexsero, 83 percent effective according to new data

Preliminary data from the world's first national meningitis B immunization program with Bexsero, launched one year ago in the UK, shows the estimated effectiveness of the vaccine at 83 percent against any meningitis B strain and 94 percent against vaccine preventable strains, for all children receiving the first two of three recommended doses. Reported cases ["]